Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome

Journal of Applied Physiology

Volumn 104, Issue 4, 2008, Pages 1101-1108

  Almlén, Andreas ^a   Stichtenoth, Guido ^a   Linderholm, Bim ^a   Haegerstrand Björkman, Marie ^a   Robertson, Bengt ^a   Johansson, Jan ^b   Curstedt, Tore ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Pulmonary surfactant; Respiratory distress syndrome; Synthetic peptide

Indexed keywords

PHOSPHOLIPID; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; LUNG ALVEOLUS; LUNG VENTILATION; LUNG VOLUME; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RABBIT; RESPIRATORY DISTRESS SYNDROME;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; FEMALE; HUMANS; INFANT, NEWBORN; LUNG VOLUME MEASUREMENTS; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; POSITIVE-PRESSURE RESPIRATION; PREGNANCY; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANTS; RABBITS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY MECHANICS; TIDAL VOLUME;

EID: 41949085292     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00865.2007     Document Type: Article

References (40)

1. Ainsworth SB, Beresford MW, Milligan DWA, Shaw NJ, Matthews JNS, Fenton AC, Ward Platt MP. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 wk gestation: a randomised trial. Lancet 355: 1387-1392, 2000.
2. Almlén A, Stichtenoth G, Robertson B, Johansson J, Curstedt T. Concentration-dependence of a poly-leucine surfactant protein C analog on in vitro and in vivo surfactant activity. Neonatology 92: 194-200, 2007.
3. Andersson M, Curstedt T, Jörnvall H, Johansson J. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett 362: 328-332, 1995.
4. Bachofen H, Gerber U, Gehr P, Amrein M, Schürch S. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro. Biochim Biophys Acta 1720: 59-72, 2005.
5. Balaraman V, Meister J, Ku TL, Sood SL, Tam E, Killeen J, Uyehara CFT, Egan E, Easa D. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Am J Respir Crit Care Med 158: 12-17, 1998.
6. Berggren P, Curstedt T, Grossmann G, Nilsson R, Robertson B. Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids. Exp Lung Res 8: 29-51, 1985.
7. Berggren P, Rigaut JP, Curstedt T, Robertson B. Computerized image analysis of lung expansion patterns in surfactant treated immature newborn rabbits. Respir Physiol 115: 45-53, 1999.
8. Bernhard W, Mottaghian J, Gebert A, Rau GA, von der Hardt H, Poets CF. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am J Respir Crit. Care Med 162: 1524-1533, 2000.
9. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 92: 7794-7798, 1995.
10. Curstedt T, Johansson J. New synthetic surfactant-how and when? Biol Neonate 89: 336-339, 2006.
11. Curstedt T, Johansson J, Persson P, Eklund A, Robertson B, Löwenadler B, Jörnvall H. Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci USA 87: 2985-2989, 1990.
12. Curstedt T, Jörnvall H, Robertson B, Bergman T, Berggren P. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. Eur J Biochem 168: 255-262, 1987.
13. Davis AJ, Jobe AH, Häfner D, Ikegami M. Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 157: 553-559, 1998.
14. Gastiasoro-Cuesta E, Alvarez-Diaz FJ, Rey-Santano C, Arnaiz-Renedo A, Loureiro-Gonzalez B, Valls-i-Soler A. Acute and sustained effects of lucinactant versus poractant-α on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome. Pediatrics 117: 295-303, 2006.
15. Glasser SW, Detmer EA, Ikegami M, Na CL, Stahlman MT, Whitsett JA. Pneumonitis and emphysema in SP-C gene targeted mice. J Biol Chem 278: 14291-14298, 2003.
16. Gupta M, Hernández-Juviel JM, Waring AJ, Bruni R, Walther FJ. Comparison of functional efficacy of surfactant protein B analogues in lavaged rats. Eur Respir J 16: 1129-1133, 2000.
17. Halliday HL. Recent clinical trials of surfactant treatment for neonates. Biol Neonate 89: 323-329, 2006.
18. Hawgood S, Ogawa A, Yukitake K, Schlueter M, Brown C, White T, Buckley D, Lesikar D, Benson B. Lung function in premature rabbits treated with recombinant human surfactant protein-C. Am J Respir Crit Care Med 154: 484-490, 1996.
19. Johansson J, Curstedt T, Jörnvall H. Surfactant protein B: disulfide bridges, structural properties and kringle similarities. Biochemistry 30: 6917-6921, 1991.
20. Johansson J, Some M, Linderholm BM, Almlén A, Curstedt T, Robertson B. A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits. J Appl Physiol 95: 2055-2063, 2003.
21. Li J, Ikegami M, Na CL, Hamvas A, Espinassous Q, Chaby R, Nogee LM, Weaver TE, Johansson J. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry 43: 3891-3898, 2004.
22. Merritt TA, Kheiter A, Cochrane CG. Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome. Pediatr Res 38: 211-217, 1995.
23. Michna J, Jobe AH, Ikegami M. Positive-end-expiratory pressure preserves surfactant function in preterm lambs. Am J Respir Crit Care Med 160: 634-639, 1999.
24. Nilsson G, Gustafsson M, Vandenbussche G, Veldhuizen E, Griffiths WJ, Sjövall J, Haagsman HP, Ruysschaert JM, Robertson B, Curstedt T, Johansson J. Synthetic peptide-containing surfactants. Evaluation of transmembrane versus amphipathic helices and SP-C poly-valyl to polyleucyl substitution. Eur J Biochem 255: 116-124, 1998.
25. Nilsson R, Grossmann G, Robertson B. Bronchiolar epithelial lesions induced in the premature rabbit neonate by short periods of artificial ventilation. Acta Pathol Microbiol Scand [A] 88: 359-367, 1980.
26. Nogee LM. Genetic metabolisms of surfactant deficiency. Biol Neonate 85: 314-318, 2004.
27. Pérez-Gil J, Cruz A, Casals C. Solubility of hydrophobic surfactant proteins in organic solvent/water mixtures. Structural studies on SP-B and SP-C in aqueous organic solvents and lipids. Biochim Biophys Acta 1168: 261-270, 1993.
28. Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 39: 715-724, 1996.
29. Scherle W. A simple method for volumetry of organs in quantitative sterology. Mikroskopie 26: 57-60, 1970.
30. Serrano AG, Pérez-Gil J. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem Phys Lipids 141: 105-118, 2006.
31. Spragg RG, Smith RM, Harris K, Lewis J, Häfner D, Germann P. Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. J Appl Physiol 88: 674-681, 2000.
32. Stark M, Wang Y, Danielsson O, Jörnvall H, Johansson J. Determination of proteins, phosphatidylethanolamine, and phosphatidylserine in organic solvent extracts of tissue material by analysis of phenylthiocarbamyl derivatives. Anal Biochem 265: 97-102, 1998.
33. Vandenbussche G, Clercx A, Curstedt T, Johansson J, Jörnvall H, Ruysschaert JM. Structure and orientation of the surfactant-associated protein C in a lipid bilayer. Eur J Biochem 203: 201-209, 1992.
34. Walther FJ, Hernández-Juviel J, Bruni R, Waring AJ. Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats. Am J Respir Crit Care Med 156: 855-861, 1997.
35. Walther FJ, Hernández-Juviel JM, Gordon LM, Waring AJ, Stenger P, Zasadzinski JA. Comparison of three lipid formulations for synthetic surfactant with a surfactant protein B analog. Exp Lung Res 31: 563-579, 2005.
36. Waring AJ, Walther FJ, Gordon LM, Hernandez-Juviel JM, Hong T, Sherman MA, Alonso C, Alig T, Braun A, Bacon D, Zasadzinski JA. The role of charged amphipathic helices in the structure and function of surfactant protein B. J Pept Res 66: 364-374, 2005.
37. Weaver TE, Beck DC. Use of knockout mice to study surfactant protein structure and function. Biol Neonate 76: 15-18, 1999.
38. Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 63: 555-578, 2001.
39. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347: 2141-2148, 2002.
40. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68, 2005.